Stage 3 clinical trials on COVID-19 vaccines could see results before end of the year

Moderna and Pfizer are the first companies to enter Phase 3 clinical testing on a COVID-19 vaccine in the U.S. Each company plans to blind test 30,000 volunteers in hopes of having results and possibly effective vaccines by the end of the year. Meg Oliver reports.

More News